v3.25.1
Stock-Based Compensation - Schedule of Stock Option and Restricted Stock Unit Activity (Details)
$ / shares in Units, shares in Millions, $ in Millions
 3 Months Ended
Mar. 31, 2025
USD ($)
$ / shares
shares
Number of Shares  
Balances at beginning of period (in shares) | shares 5
Granted (in shares) | shares 1
Exercised/Vested (in shares) | shares (1)
Canceled (in shares) | shares 0
Balances at end of period (in shares) | shares 5
Weighted- Average Exercise Price  
Balances at beginning of period (in USD per share) | $ / shares $ 93.53
Granted (in USD per share) | $ / shares 142.06
Exercised/Vested (in USD per share) | $ / shares 48.42
Canceled (in USD per share) | $ / shares 0
Balances at end of period (in USD per share) | $ / shares $ 102.71
Number of Shares  
Balances at beginning of period (in shares) | shares 30
Granted (in shares) | shares 9
Exercised/Vested (in shares) | shares (2)
Canceled (in shares) | shares (1)
Balances at end of period (in shares) | shares 36
Weighted- Average Grant Date Fair Value  
Balances at beginning of period (in USD per share) | $ / shares $ 97.93
Granted (in USD per share) | $ / shares 141.05
Exercised/Vested (in USD per share) | $ / shares 142.72
Canceled (in USD per share) | $ / shares 140.65
Balances at end of period (in USD per share) | $ / shares $ 105.33
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]  
Options outstanding (in shares) | shares 5
Options outstanding (in USD per share) | $ / shares $ 102.71
Options outstanding, weighted-average remaining contractual life (in years) 5 years 8 months 8 days
Options outstanding, aggregate intrinsic value | $ $ 173
Options exercisable (in shares) | shares 4
Options excisable (in USD per share) | $ / shares $ 87.88
Options exercisable, weighted-average remaining contractual life (in years) 4 years 7 months 17 days
Options exercisable, aggregate intrinsic value | $ $ 171